ANNX250117C4000
- 0.40
- 0.000.00%
Annexon Newsroom
BofA Securities Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $12
Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), Immunovant (IMVT)
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $12 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Annexon Analyst Ratings
Annexon Biosciences' ANX005: Strong Buy Rating Backed by Promising Efficacy and Sales Potential
Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Annexon Analyst Ratings
Annexon Biosciences: Buy Rating Backed by Promising Data Releases and Strategic Long-term Potential
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
TD Cowen Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)
Wells Fargo Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $14
Buy Rating Affirmed for Annexon Biosciences Amidst Promising Clinical Developments and Market Potential
Annexon Analyst Ratings
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating